Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

11.40
+0.11000.97%
Post-market: 11.400.00000.00%19:30 EDT
Volume:218.90K
Turnover:2.48M
Market Cap:399.77M
PE:-95
High:11.47
Open:11.29
Low:10.88
Close:11.29
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.78M
Volume Ratio:1.16
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:9.42
PE(LYR):-33.44

Loading ...

Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand

Reuters
·
May 14

Fennec Pharmaceuticals Q1 Net Income USD 201 Thousand

THOMSON REUTERS
·
May 14

Fennec Pharmaceuticals Q1 Operating Expenses USD 15.227 Million

THOMSON REUTERS
·
May 14

Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 14

Fennec Pharma director Chris Rallis disposes 8,346 common shares for $58,755.84

Reuters
·
May 13

Fennec Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
May 12

Fennec Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
May 08

Fennec says four PEDMARK studies accepted for presentation at 2026 ASCO meeting

Reuters
·
May 07

Fennec Pharmaceuticals to report first-quarter 2026 results, hosts conference call and webcast

Reuters
·
May 07

Fennec Pharma director Rosty Raykov disposes of common shares worth $69,754.07

Reuters
·
May 02

Fennec Pharma director Rostislav Raykov to retire, not seek re-election

Reuters
·
Apr 29

Fennec Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 29

Piper Sandler Remains a Buy on Fennec Pharmaceuticals (FENC)

TIPRANKS
·
Apr 23

Far Eastern New Century Perluas Pendidikan Ekonomi Kitaran Seluruh Dunia Majukan Impak Kelestarian

prnewswire
·
Apr 23

Far Eastern New Century Expands Circular Economy Education Worldwide to Advance Sustainability Impact

prnewswire
·
Apr 22

Fennec says four PEDMARK studies accepted for presentation at ASCO annual meeting

Reuters
·
Apr 22

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Apr 22

Fennec Pharmaceuticals Price Target Maintained With a $13.00/Share by Wedbush

Dow Jones
·
Apr 16

Fennec Pharmaceuticals (FENC) Receives a Buy from Wedbush

TIPRANKS
·
Apr 16

BUZZ-Fennec up on study testing expanded use of its hearing‑loss prevention drug in cancer patients

Reuters
·
Apr 07